Cited by 432Frailty in Older AdultsEthics in Clinical ResearchNutrition and Health in Aging

Under-Representation of Older Adults in Cancer Registration Trials: Known Problem, Little Progress

Scher, Kevin S., Hurria, Arti·2012·Journal of Clinical Oncology

Abstract

The oncology literature from the last decade is replete with articleslamentingthescarcityofdatatoguidetreatmentdecisionsforthe elderly population with cancer. With the aging of the United States and worldwide population and the known association between older ageandcancer, 1 cliniciansandresearchersunderstandtheimportance of studying the efficacy and toxicity of cancer therapies in this at-risk population. The importance of this knowledge is highlighted by the US Food and Drug Administration in its Guideline for the Study of Drugs Likely to Be Used in the Elderly, 2 which advocates enrollment of older adults in clinical trials as a means to understand treatment effects among differing populations. Almostadecadeago,JournalofClinicalOncologyhighlightedthe under-representation of older adults in registration trials for new cancertherapiesfrom1992to2002.Talaricoetal 3 showedtheproportions enrolled onto registration trials versus the proportions in the overall populations age 65, 70, and 75 years were 36%, 20%, and9%comparedwith60%,46%,and31%,respectively.Theauthors surmised that decline in functional reserve, increased comorbid con

Integrity signals

Registry

Crossref · 10.1200/jco.2012.41.6727

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The inclusion of elderly patients in clinical cancer studies is usually insufficient.

    “their inclusion in clinical studies is usually insufficient, as patients over 75 years of age represent less than 10% of patients with cancer [150, 151]”

    From Immunosenescence: a key player in cancer development (2020) · cites this paper as [150]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Scher, K. S., & Hurria, A.
Affiliations
City Of Hope National Medical Center (US)
Venue
Journal of Clinical Oncology
Published
2012-06-10
Volume
30
Issue
17
Pages
2036-2038
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2045805729
Cited by
432
References
4
Citations by year
2026: 13 · 2025: 28 · 2024: 25 · 2023: 29 · 2022: 41 · 2021: 39 · 2020: 53 · 2019: 30 · 2018: 41 · 2017: 31 · 2016: 25 · 2015: 24 · 2014: 25 · 2013: 15 · 2012: 13
FWCI
12.08
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
Keywords
older adults, underrepresentation in clinical trials, clinical trial recruitment, geriatric oncology, comorbidities, functional reserve
MeSH terms
Aged, Antineoplastic Agents, Clinical Trials as Topic, Geriatrics, Humans, Medical Oncology, Neoplasms, Patient Participation, United States, Drug Approval, SEER Program, Patient Selection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review